Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 2:10:926002.
doi: 10.3389/fchem.2022.926002. eCollection 2022.

Preparation of NIR-Responsive Gold Nanocages as Efficient Carrier for Controlling Release of EGCG in Anticancer Application

Affiliations

Preparation of NIR-Responsive Gold Nanocages as Efficient Carrier for Controlling Release of EGCG in Anticancer Application

Weiran Gao et al. Front Chem. .

Abstract

Hepatocellular carcinoma (HCC) is a type of cancer that has a restricted therapy option. Epigallocatechin gallate (EGCG) is one of the main biologically active ingredients in tea. A large number of studies have shown that EGCG has preventive and therapeutic effects on various tumors. In addition, the development of near-infrared (NIR)-responsive nano-platforms has been attracting cancer treatment. In this work, we designed and synthesized a strategy of gold nanocages (AuNCs) as an efficient carrier for controlling release of EGCG for anti-tumor to achieve the synergistic functions of NIR-response and inhibited tumor cell proliferation. The diameter of AuNCs is about 50 nm and has a hollow porous (8 nm) structure. Thermal imaging-graphic studies proved that the AuNCs-EGCG obtained have photothermal response to laser irradiation under near-infrared light and still maintain light stability after multiple cycles of laser irradiation. The resulted AuNCs-EGCG reduced the proliferation rate of HepG2 cells to 50% at 48 h. Western blot analysis showed that NIR-responsive AuNCs-EGCG can promote the expression of HepG2 cell apoptosis-related proteins HSP70, Cytochrome C, Caspase-9, Caspase-3, and Bax, while the expression of Bcl-2 is inhibited. Cell confocal microscopy analysis proved that AuNCs-EGCG irradiated by NIR significantly upregulates Caspase-3 by nearly 2-fold and downregulates Bcl-2 by nearly 0.33-fold, which is beneficial to promote HepG2 cell apoptosis. This study provides useful information for the NIR-responsive AuNCs-EGCG as a new type of nanomedicine for HCC.

Keywords: NIR responsive; epigallocatechin gallate; gold nanocages; hepatocellular carcinoma; photothermal therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

SCHEME 1
SCHEME 1
Schematic diagram of the synthesis of AuNCs-EGCG and its effect on cells under near-infrared radiation. AuNCs-EGCG can promote tumor cell apoptosis.
FIGURE 1
FIGURE 1
Characterization of AuNCs and EGCG-AuNCs. (A) TEM images and (B) DLS size distribution of AuNCs. (C) FTIR spectra, (D) XRD, (E) UV-vis and (F) fluorescence emission (λex = 400 nm) of samples. (G) Temperature rise curves of AuNCs-EGCG at different concentrations within 10 min. (H) Temperature rise curves of three groups of samples within 10 min. (I) The thermal curves of AuNCs and EGCG-AuNCs after repeated laser irradiation (n = 3). (J) Infrared thermography images of samples under 808 nm laser irradiation for 5 min.
FIGURE 2
FIGURE 2
Drug release from AuNCs-EGCG. (A) The release of EGCG from AuNCs-EGCG with or without laser irradiation. (B) The drug release curve of AuNCs-EGCG.
FIGURE 3
FIGURE 3
UV spectra of ABDA solution in control group and AuNCs-EGCG group.
FIGURE 4
FIGURE 4
NIR-responsive AuNCs-EGCG inhibited proliferation of HepG2 cells. (A) Effects of NIR-responsive AuNCs-EGCG at different times on the proliferation of HepG2 cells observed by MTT method. The mean and standard deviation (SD) of the data (n = 3) are shown. Statistical analysis: ∗∗∗ p < 0.001. (B) Fluorescent images of Live/Dead-stained HepG2 cells after different treatments. Green: live cell staining, Red: dead cell staining. Scale bars are 25 μm.
FIGURE 5
FIGURE 5
NIR-responsive AuNCs-EGCG promoted HepG2 apoptosis. (A–G) The effect of NIR-responsive AuNCs-EGCG on the expression of HepG2 apoptosis-related proteins was detected by western blot and semi-quantitative analysis. The mean and standard deviation (SD) of the data (n = 3) are shown. Statistical analysis: ∗∗∗ p < 0.001.
FIGURE 6
FIGURE 6
NIR-responsive AuNCs-EGCG promoted the expression level of Caspase-3 protein in HepG2 cells (A,B). Confocal microscopy immunofluorescence analysis of Caspase-3 protein expression and its semi-quantification analysis. Scale bars are 25 μm. The mean and standard deviation (SD) of the data (n = 3) are shown. Statistical analysis: ∗∗∗ p < 0.001.
FIGURE 7
FIGURE 7
NIR-responsive AuNCs-EGCG inhibited the expression level of Bcl-2 protein in HepG2 cells (A,B). Confocal microscopy immunofluorescence analysis of Bcl-2 protein expression and its semi-quantification analysis. Scale bars are 25 μm. The mean and standard deviation (SD) of the data (n = 3) are shown. Statistical analysis: ∗∗∗ p < 0.001.

Similar articles

Cited by

References

    1. Abe O., Ono T., Sato H., Müller F., Ogata H., Miura I., et al. (2018). Role of (−)-epigallocatechin Gallate in the Pharmacokinetic Interaction between Nadolol and Green Tea in Healthy Volunteers. Eur. J. Clin. Pharmacol. 74 (6), 775–783. 10.1007/s00228-018-2436-2 - DOI - PubMed
    1. Alshatwi A. A., Periasamy V. S., Athinarayanan J., Elango R. (2016). Synergistic Anticancer Activity of Dietary Tea Polyphenols and Bleomycin Hydrochloride in Human Cervical Cancer Cell: Caspase-dependent and Independent Apoptotic Pathways. Chemico-biological Interact. 247, 1–10. 10.1016/j.cbi.2016.01.012 - DOI - PubMed
    1. Basu A. (2022). The Interplay between Apoptosis and Cellular Senescence: Bcl-2 Family Proteins as Targets for Cancer Therapy. Pharmacol. Ther. 230, 107943. 10.1016/j.pharmthera.2021.107943 - DOI - PubMed
    1. Bhat K. P. L., Pezzuto J. M. (2002). Cancer Chemopreventive Activity of Resveratrol. Ann. N. Y. Acad. Sci. 957, 210–229. 10.1111/j.1749-6632.2002.tb02918.x - DOI - PubMed
    1. Cammarota A., D'Alessio A., Pressiani T., Rimassa L., Personeni N. (2021). Systemic Treatment for Older Patients with Unresectable Hepatocellular Carcinoma. Drugs aging 38 (7), 579–591. 10.1007/s40266-021-00871-5 - DOI - PubMed